Literature DB >> 908869

Evidence of aluminum absorption from the gastrointestinal tract and bone deposition by aluminum carbonate ingestion with normal renal function.

R R Recker, A J Blotcky, J A Leffler, E P Rack.   

Abstract

The question of whether aluminum is toxic in patients ingesting large oral loads, either for phosphate binding in renal dialysis or as an antacid for peptic ulcer, has been raised. The permeability of the gut barrier for aluminum has not been established because of the lack of precise analytical techniques. Urine aluminum was measured in this study before and during oral aluminum carbonate loading in six subjects with normal renal function, one of which had peptic ulcer disease and a 25-year history of high oral aluminum ingestion. The analytical procedure involved destructive neutron activation analysis. Aluminum was present in the urine in all instances before loading and rose in every case from 4-fold to 10-fold. Bone aluminum was measured in six autopsy specimens, three dialysis patients, three nondialysis patients, and in an iliac crest biopsy from the peptic ulcer patient who had osteoporosis. The bone biopsy aluminum level in the ulcer patient was intermediate between those of "normal subjects" and patients on dialysis. These results show that the gut barrier is permeable to heavy aluminum load and suggest that bone aluminum deposition occurs in humans with normal renal function.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 908869

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  15 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

2.  Storage and Pre-Neutron Activation Analysis Treatment for Trace Element Analysis in Urine.

Authors:  Alan J Blotcky; Edward P Rack
Journal:  J Res Natl Bur Stand (1977)       Date:  1986 Mar-Apr

Review 3.  Assessing the safety of drugs for the long-term treatment of peptic ulcers.

Authors:  K G Wormsley
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

Review 4.  Antacid and sucralfate-induced hypophosphatemic osteomalacia: a case report and review of the literature.

Authors:  A Chines; R Pacifici
Journal:  Calcif Tissue Int       Date:  1990-11       Impact factor: 4.333

5.  Effect of aluminum on normal and uremic rats: tissue distribution, vitamin D metabolites, and quantitative bone histology.

Authors:  Y L Chan; A C Alfrey; S Posen; D Lissner; E Hills; C R Dunstan; R A Evans
Journal:  Calcif Tissue Int       Date:  1983-05       Impact factor: 4.333

6.  Aluminum accumulation in serum, liver and spleen of Fe-depleted and Fe-adequate rats.

Authors:  T S Brown; R Schwartz
Journal:  Biol Trace Elem Res       Date:  1992-07       Impact factor: 3.738

7.  Mortality from dementia among gastroduodenal ulcer patients.

Authors:  T P Flaten; E Glattre; A Viste; O Søoreide
Journal:  J Epidemiol Community Health       Date:  1991-09       Impact factor: 3.710

8.  Radiographic manifestations of experimental aluminum toxicity in growing bone.

Authors:  R J Hernandez; A B Sedman; D M Smid; W G Goodman
Journal:  Skeletal Radiol       Date:  1987       Impact factor: 2.199

9.  X-ray microanalysis of ossified auricles in Addison's disease.

Authors:  A M Cohen; Y P Talmi; S Floru; R Tsigelman; M Kalmanovitz; Y Zohar; M Djaldetti
Journal:  Calcif Tissue Int       Date:  1991-02       Impact factor: 4.333

10.  Plasma and urine aluminium concentrations in healthy subjects after administration of sucralfate.

Authors:  P Allain; Y Mauras; N Krari; J Duchier; A Cournot; J Larcheveque
Journal:  Br J Clin Pharmacol       Date:  1990-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.